For individuals with obesity, metabolic-bariatric surgery (MBS) is associated with a reduced risk for pancreatic cancer.

“Neoadjuvant chemotherapy is what we term for individuals that need chemotherapy prior to surgery,” said Philip Kovoor, MD, ...

Regular aspirin use significantly lowers the risk of developing pancreatic cancer, a study has found. Research funded by PLANETS Cancer Charity and carried out by University Hospital Southampton and ...

RNA vaccines have gained widespread attention for their crucial role in fighting the COVID-19 pandemic. Yet, even before the ...

Understand how metabolic-bariatric surgery reduces pancreatic cancer risk in obese diabetic patients, offering a significant ...